# EDGAR Filing Document

**Accession Number:** 0002007702
**File Stem:** 0000000000-26-003341
**Filing Date:** 2026-4
**Character Count:** 2551
**Document Hash:** 6bf0f91793165951acf3220ba6057174
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-26-003341.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0000000000-26-003341

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260402

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Cellyan Biotechnology Co., Ltd
- **CENTRAL INDEX KEY:** 0002007702
- **STANDARD INDUSTRIAL CLASSIFICATION:** WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 333-294685

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM B1, 5/F. WELL TOWN IND. BUILDING
- **STREET 2:** 13 KO FAI ROAD, YAU TONG
- **CITY:** KOWLOON
- **PROVINCE COUNTRY:** K3
- **BUSINESS PHONE:** (852) 26189289

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** ROOM B1, 5/F. WELL TOWN IND. BUILDING
- **STREET 2:** 13 KO FAI ROAD, YAU TONG
- **CITY:** KOWLOON
- **PROVINCE COUNTRY:** K3

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Hong Kong Pharma Digital Technology Holdings Ltd
- **DATE OF NAME CHANGE:** 20240110
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001213900-26-035450

## Text-Extract

```

                                                           April 2, 2026

Chinyu Liang
Chief Executive Officer
Cellyan Biotechnology Co., Ltd
Room B1, 5/F., Well Town Industrial Building
13 Ko Fai Road, Yau Tong, Kowloon
Hong Kong

       Re: Cellyan Biotechnology Co., Ltd
           Registration Statement on Form F-1
           Filed March 27, 2026
           File No. 333-294685
Dear Chinyu Liang:

       This is to advise you that we have not reviewed and will not review your
registration
statement.

        Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

       Please contact Kate Beukenkamp at 202-551-3861 with any questions.

                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of Trade &
Services
cc:    Zhaocong "Richard" Xu

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._